Difference of gene expression profiles between Barrett’s esophagus and cardia intestinal metaplasia by gene chip

Abstract

The difference of gene expression profile changes in Barrett’s esophagus (BE) and cardia intestinal metaplasia (CIM) epithelium was studied and the novel associated genes were screened in the carly stage by cDNA microarray. The cDNA retro-transcribed from equal quantity mRNA from BE and CIM epithelial tissues were labeled with Cy3 and Cy5 fluorescence as probes. The mixed probe was hybridized with three pieces BiostarH-40s double dot human whole gene chip. The chips were scanned with a ScanArray 4000. The acquired images were analyzed using GenePix Pro 3.0 software. It was found a total of 141 genes were screened out that exhibited differentially expression more than 2 times in all three chips. It was identified that in gene expression profiles of BE, 74 genes were up-regulated and 67 down-regulated as compared with CIM. The comparison between the difference of gene expression profile changes in BE and CIM epithelia revealed that there existed the difference between BE and CIM at gene level. 141 genes with the expression more than two time were probably related to the occurrence and development of BE and the promotion or progress in adenocarcinoma.

Keywords

Barrett’s esophagus / cardia intestinal metaplasia / gene expression profile

References

[1] O’ConnorJ B, FalkG W, RichterJ E. The incidence of adenocarcinoma and dysplasia in Barrett’s esophagus: report on the Cleveland Clinic Barrett’s Esophagus Registry. Am J Gastroenterol, 1999, 94: 2037-2042

[2] GeboesK. Barrett’s esophagus: the metaplasia-dysplasia-carcinoma sequence: morphological aspects. Acta Gastroenterol Belg, 2000, 63: 13-17

[3] MoralesT G, SamplinerR E, BhattacharyyaT. Intestinal metaplasia of the cardia. Am J Gastroenterol, 1997, 92: 414-418

[4] VoutilainenM, FarkkilaM, JuholaM, et al.. Complete and incomplete intestinal metaplasia at the oesophagogastric junction: prevalences and associations with endoscopic erosive oesophagitis and gastritis. Gut, 1999, 45(5): 644-648

[5] GoldsteinN S, KarimR. Gastric cardia inflammation and intestinal metaplasia: associations with reflux esophagitis and helicobacter pylori. Mod Pathol, 1999, 12: 1017-1024

[6] RoulA, ParentiA, ZaninottoG, et al.. Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett’s esophagus and adenocarcinoma of the gastric cardia. Cancer, 2000, 88: 2520-2526

[7] ByrneJ P, MathersJ M, ParryJ M, et al.. Site distribution of oesophagogastric cancer. Clin Pathol, 2002, 55(3): 191-194

[8] GarethS, SushovanG, KatherineL, et al.. Preoperative prevalence of Barrett’s esophagus in esophageal adenocarcinoma: A systematic review. Gastroenterology, 2002, 122: 26-33

[9] SharmaP, WestonA P, MoralesT, et al.. Relative risk of dysplasia for patients with intestinal metaplasia in the distal esophagus and in the gastric cardia. Gut, 2000, 46: 9-13

[10] SchenaM, ShalonD, DavisR W, et al.. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science, 1995, 270: 467-470